Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Human CD19-CD22 Targeted T Cells Injection for Refractory/Relapsed Central Nervous System Leukemia/Lymphoma Patients

Hrain Biotechnology Co., Ltd. · 2022
ClinicalTrials.gov · Datasets · License: Public Domain · 2022
Open Source ↗
central nervous system lymphoma, cd19-cd22, car-t, central nervous system leukemia/lymphoma, refractory/relapsed, interventional, early_phase1
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 908432
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.